002422 科倫藥業
按盤價 
38.000 +1.050 (+2.842%)
38.000 +1.050 (+2.842%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.336 | 13.930 | 13.874 | 11.526 | 8.061 |
| 總資產報酬率 ROA (%) | 2.621 | 7.959 | 6.952 | 5.188 | 3.471 |
| 投入資產回報率 ROIC (%) | 3.503 | 10.511 | 8.957 | 6.621 | 4.357 | 邊際利潤分析 |
| 銷售毛利率 (%) | 49.757 | 51.693 | 52.430 | 52.516 | 55.664 |
| 營業利潤率 (%) | 16.662 | 20.293 | 17.033 | 11.530 | 7.639 |
| 息稅前利潤/營業總收入 (%) | 15.956 | 19.950 | 17.779 | 13.382 | 9.743 |
| 淨利潤/營業總收入 (%) | 12.263 | 15.413 | 12.336 | 8.952 | 5.025 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 89.222 | 92.444 | 88.720 | 87.756 | 83.807 |
| 價值變動淨收益/利潤總額(%) | 10.454 | 8.515 | 10.433 | 11.821 | 18.653 |
| 營業外收支淨額/利潤總額(%) | -6.757 | -3.289 | -2.059 | -6.152 | -12.078 | 償債能力分析 |
| 流動比率 (X) | 2.158 | 1.963 | 1.830 | 1.376 | 1.045 |
| 速動比率 (X) | 1.765 | 1.547 | 1.446 | 1.110 | 0.794 |
| 資產負債率 (%) | 26.595 | 28.347 | 36.866 | 50.678 | 55.201 |
| 帶息債務/全部投入資本 (%) | 15.750 | 14.876 | 27.324 | 39.040 | 42.213 |
| 股東權益/帶息債務 (%) | 510.850 | 545.555 | 255.616 | 151.090 | 132.162 |
| 股東權益/負債合計 (%) | 228.003 | 212.510 | 146.379 | 90.766 | 79.589 |
| 利息保障倍數 (X) | 45.723 | 65.754 | 16.317 | 5.310 | 3.329 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 97.406 | 78.213 | 87.082 | 103.975 | 114.391 |
| 存貨周轉天數 (天) | 145.265 | 130.521 | 124.413 | 130.958 | 160.520 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 24/09/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
